🔴 SeaStar Medical is trading 9.1% down in pre-market

SeaStar Medical is trading 9.13% down at $3.38 in pre-market on October 8; no new company announcement explaining the decline was found.

• The FDA granted its SCD therapy Breakthrough Device Designation for adult sepsis-related hyperinflammation on October 7; that earlier positive news does not explain the current drop.
• The Nasdaq was down 0.56% and the Dow 0.57% in the supplied context. This may contribute to risk-off sentiment but does not establish the cause of the decline.